26.03.2015 Views

19SafQB

19SafQB

19SafQB

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

3.7 Auto_ID — Value Creation from Big Data and Serialization 189<br />

now. The biologics industry has been a pioneer in re-establishing data linkages<br />

between pharmaceutical manufacturers and clinical service providers in the<br />

context of developing stratified medicine and autologous cell based therapies<br />

which require matching the right cells with the right patients.<br />

We can see this linkage of product and patient outcomes at the center of the<br />

“7 Flows” model proposed by Genzyme executive Laurent Boer, VP Global<br />

Distribution & Logistics and General Manager of the Genzyme Northborough<br />

Operations Center, as a framework to think about the kinds of data that are<br />

required for managing pharmaceutical industry processes [25 Boer, 2013].<br />

Fig. 3.19 The 7 flows of supply chain information — Laurent Boer, VP global distribution & logistics,<br />

Genzyme — Sanofi [32].<br />

In the following section we will review these (7) data protocols. The<br />

connection between a product and a patient outcome is an area of great<br />

promise for pharmaceutical manufacturers developing stratified medicine<br />

therapeutics.<br />

3.7.1.2 Tracking serialized products<br />

In the healthcare industry there is no question that both regulatory agencies and<br />

pharmaceutical product manufacturers would be better off with identification<br />

systems for tracking products, producers, production sites as well as individual

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!